A clinical trial to study the effects of two drugs,Eugenia jambolana and Syzygium caryophyllatum leaf in patients with Acne vulgaris

Phase 1

Not yet recruiting

• Conditions: Other specified local infections of the skin and subcutaneous tissue,

• Registration Number: CTRI/2020/03/023942
• Lead Sponsor: Ravindra H L

Brief Summary

Jambu and Kshudra jambu are used by folklore practicioners of western ghats for the treatment of Acne vulgaris. Jambu has property similar to that of kshudra jambu and is said to be twak prasadaka and vrana ropaka. Acne is a common skin condition having prevalence rate of 76.2%. An attempt is made to find a cost-effective drug for the treatment of Acne vulgaris and also to compare the two Jambu varieties clinically.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-02-27
• Study Start: 2020-03-18

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 133920

Inclusion Criteria

Shalmali kantaka pidaka, Sarika pidaka, Ghana pidaka, medogarbha.

Exclusion Criteria

• Any systemic illness that requires treatment which might interfere with present clinical trial.
• Diabetis mellitus, hypertension,Acne rosaceae, Syncosis barbar, gram negative folliculitis.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease management	Disease management

Secondary Outcome Measures

Name	Time	Method
Minimum side effects and less reoccurence of signs and symptoms	30 days after the stopage of intervention

Trial Locations

Locations (1)

SDM College of ayurveda; 🇮🇳 Udupi, KARNATAKA, India

SDM College of ayurveda

🇮🇳Udupi, KARNATAKA, India

Dr Shrikanth P

Principal investigator

9449329823

drshrikanth.acharya@gmail.com